Neoplasms, Colorectal Recruiting Phase 2 Trials for Capecitabine (DB01101)

Also known as: Colorectal Neoplasms / Colorectal Neoplasm / Neoplasms,Colorectal

IndicationStatusPhase
DBCOND0036298 (Neoplasms, Colorectal)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04080843Anlotinib Hydrochloride Capsules Combined With CAPEOX in RAS and BRAF Wild-type mCRC PatientsTreatment
NCT01880658Phase II Study of Maintenance Capecitabine to Treat Resectable Colorectal CancerTreatment
NCT02870153SOX Versus XELOX for Patients With Peritoneal Metastasis of Colorectal CancerTreatment
NCT03280407NEOadjuvant Chemotherapy Only Compared With Standard Treatment for Locally Advanced Rectal CancerTreatment